Amarantus Bioscience Holdings Inc (AMBS)

[JPetroInc]

both compelling sides of the same coin made here

both well written and thought out

questions remain:

1.) after 3 + long years, can AMBS get "any" non-toxic funding whatsoever - without diminishing ownership of their Tx or Dx assets?
2.) can they obtain the backing of "any"reputable IB - and soon?
3.) will AMBS continue to "go it alone" indefinitely, all at the expense of further 'wasting' their shareholder base - what ever is left of it?

stats:

1.) down 90% fron YH of $0.195 ($29.25) to $0.017 ($2.60) in 12 months
2.) down 78% from Pre-RS of $0.08 ($12.00) to $0.015 ($2.6) in

either this recent unprecedented and catostrophic loss of value was the act of shorts working in concert, or provided AMBS actually uplists (which I unequivocally believe they will), we're watching the irrefutable transfer of wealth from the retail to large institutionals and AMBS insiders

the biggest observable faults which have added to the current demise in PPS has been:

1.) a huge RS when advertised as "coming from stregnth"
2.) followed by 500,000 share equity distributuion to the lenders
3.) followed by ASM announcement of 35-Mil. AS increase
4.) all without 1-red cent of revenue, grants, JV's or non-toxic financing

to AMBS BOD/BOA - for once and for all:

we the investmnet community need to be permanently unburden of AMBS's toxic death spiral financing involving $1.8-Mil. mo. burn ($21-Mil./yr.), high flutting salaries and extensive Dx & Tx development fee's